ClinicalTrials.gg
RecruitingNCT06731114Updated Dec 12, 2024

"Additional Effects of Sternocleidomastoid Release Along With Suboccipital Muscle Release in Management of Cervicogenic Headache'

An interventional study of Suboccipital muscle release and Conventional physical therapy in Cervicogenic Headache, sponsored by Foundation University Islamabad. Recruiting at 1 site in Pakistan. Open to participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2024-12-12.

Sponsored by Foundation University Islamabad · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Jul 2025, 1 year 3 months ago, but the record still lists the study as recruiting.
  • Registered 4 months after the study started (first participant enrolled Jul 2024, registered Dec 2024).
  • Started Jul 2024; still recruiting 2 years 3 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
54
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
All
01

Study summary

This study is a randomised control trial and the purpose of this study is to determine the "Additional effects of sternocleidomastoid release along with suboccipital muscle release in management of cervicogenic headache".

Read the detailed description

Cervicogenic headache is a common headache that causes disability and affects everyday activities. Headache related disorders are the second most common reason for years lived with disability all over the world. According to the latest International Headache Society model, cervicogenicheadache (CGH) is a secondary headache having C1-C2 dysfunction. There is marked limitation in cervical ROM specially rotation. Treatment indicated involves use of electrotherapy and thermal modalities. In addition, use of different manual therapy techniques are advocated to eliminate the root cause i.e. C1-C2 dysfunction treating. patients with cervicogenic headache are mostly presented with forward head posture and weak deep neck flexors which may excerbate the headache symptoms.Therefore The purpose of this study is to determine the ""Additional effects of sternocleidomastoid release along with suboccipital muscle release in management of cervicogenic headache

02

Conditions studied

  • Cervicogenic Headache
03

In context

Post-Traumatic Headache

192 studies on the registry are indexed under Post-Traumatic Headache; 54 are open to participants now.

This study's planned enrollment of 54 is above the median of 44 across 169 interventional studies indexed under Post-Traumatic Headache.

Browse Post-Traumatic Headache studies →

Lead sponsor

Foundation University Islamabad is the lead sponsor of 255 studies on the registry; 142 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Participants will be included according to international classification of headache criteria which includes:
  • Headache with neck stiffness
  • Headache at least once a month in the last 3 months
  • Headache with at least 4 score in Numeric Pain Rating Scale(NPRS)
  • Unilateral headache with no shift of side
  • Positive flexion rotation test (Rotation restriction is greater than 10 degrees)
  • C1-C2 dysfunction
  • Headache precipitated by sustained neck movements,myofacial trigger points palpation in neck
  • Age group 18-45
  • Both male and female

Exclusion criteria

Exclusion Criteria:

  • Cervical spondylosis
  • Headache of non-cervical origin
  • Dizziness or visual disturbance
  • Cervical radiculopathy/ nerve root involvement/ disc herniation
  • Cervical instability/ fracture
  • Vertebrobasilar insufficiency
  • Thoracic outlet syndrome
  • Cervical spine surgery
  • Cervical spondylolisthesis
  • Spinal infection or tumors
  • Osteoporosis
  • meningitis
  • subarachnoid hemorrhage
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
54 participants (estimated)

Study arms

  • Experimental
    Group A

    On group A we will perform suboccipital muscle release (3 repititions 3 mins)9 minutes along with conventional physical therapy including TENS and hot pack for 10 mins 6 days a week for consective 2 weeks.

    Procedure: Suboccipital muscle release · Procedure: Conventional physical therapy

  • Experimental
    Group B

    On group B we will perform sternocleidomastoid release for 5 mins along with suboccipital muscle release and coventional physical therapy including TENS and hot pack for 10 mins 6 days a week for consective 2 weeks .

    Procedure: Suboccipital muscle release · Procedure: Conventional physical therapy · Procedure: Sternocleidomastoid release

Interventions

  • ProcedureSuboccipital muscle release

    Suboccipital muscle release.6 consecutive sessions for 2 weeks • Frequency:( 3mins 3 reps) 9 mins .12 sessions in total

  • ProcedureConventional physical therapy

    TENS and hot pack for 10 mins 6 days a week for consecutive 2 weeks

  • ProcedureSternocleidomastoid release

    Frequency: 5 mins of SCM release and 9 mins (3 mins 3 reps )of suboccipital release. 12 sessions in total.

06

What researchers measure

Primary outcomes

  1. Pain Intensity

    Pain will be measured on the basis of Numeric Pain Rating Scale score.

    Time frame: 2 weeks

  2. ROM

    Cervical rotation will be measured through CROM device

    Time frame: 2 weeks

07

Study locations

1 of 1 sites recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 12, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06731114
Responsible party
Sponsor
First posted
Dec 12, 2024
Start date
Jul 15, 2024
Primary completion
Jul 15, 2025 (estimated)
Completion
Jul 15, 2025 (estimated)
Last update
Dec 12, 2024

Study contacts

Ayesha Arshad, MS-MSKPT
Contact
aesharshad4200@gmail.com
03315314699

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion